Buonomo AR - Search Results

1

Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge.

Scotto R, Buonomo AR, Zumbo G, Di Fusco A, Esposito N, Di Filippo I, Nobile M, Pinchera B, Schiano Moriello N, Villari R, Gentile I, Federico Ii Covid Team. Scotto R, et al. Among authors: buonomo ar. Vaccines (Basel). 2022 Nov 10;10(11):1895. doi: 10.3390/vaccines10111895. Vaccines (Basel). 2022. PMID: 36366403 Free PMC article.

2

Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.

Gentile I, Bonadies G, Buonomo AR, Minei G, Borrelli F, Foggia M, Chiurazzi F, Borgia G. Gentile I, et al. Among authors: buonomo ar. Platelets. 2013;24(7):574-7. doi: 10.3109/09537104.2012.735721. Epub 2012 Nov 6. Platelets. 2013. PMID: 23130846 Free article.

3

Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report.

Gentile I, De Stefano A, Di Flumeri G, Buonomo AR, Carlomagno C, Morisco F, De Placido S, Borgia G. Gentile I, et al. Among authors: buonomo ar. In Vivo. 2013 Jul-Aug;27(4):527-9. In Vivo. 2013. PMID: 23812225

4

A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir.

Gentile I, Borgia F, Buonomo AR, Castaldo G, Borgia G. Gentile I, et al. Among authors: buonomo ar. Curr Med Chem. 2013;20(30):3733-42. doi: 10.2174/09298673113209990178. Curr Med Chem. 2013. PMID: 23848533 Review.

5

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era.

Gentile I, Borgia F, Zappulo E, Buonomo AR, Spera AM, Castaldo G, Borgia G. Gentile I, et al. Among authors: buonomo ar. Rev Recent Clin Trials. 2014;9(1):1-7. doi: 10.2174/1574887108666131213120354. Rev Recent Clin Trials. 2014. PMID: 23859195 Review.

6

A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.

Gentile I, Coppola N, Pasquale G, Liuzzi R, D'Armiento M, Di Lorenzo ME, Capoluongo N, Buonomo AR, Sagnelli E, Morisco F, Caporaso N, Borgia G. Gentile I, et al. Among authors: buonomo ar. Hepat Mon. 2013 May 8;13(5):e8352. doi: 10.5812/hepatmon.8352. eCollection 2013 May. Hepat Mon. 2013. PMID: 23967022 Free PMC article.

7

In vivo antiviral activity of telbivudine against HIV-1: a case report.

Gentile I, Bonadies G, Carleo MA, Buonomo AR, Borrelli F, Portella G, Borgia G. Gentile I, et al. Among authors: buonomo ar. Infez Med. 2013 Sep;21(3):216-9. Infez Med. 2013. PMID: 24008855 Free article.

8

Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature.

Fusco F, D'Anzeo G, Rossi A, Sciorio C, Buonomo AR, d'Emmanuele di Villa Bianca R, Borgia G, Mirone V, Gentile I. Fusco F, et al. Among authors: buonomo ar. Expert Opin Pharmacother. 2013 Dec;14(18):2533-44. doi: 10.1517/14656566.2013.850073. Epub 2013 Nov 12. Expert Opin Pharmacother. 2013. PMID: 24215104 Review.

9

Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection.

Gentile I, Meola M, Buonomo AR, Minei G, Coppola N, Foggia M, Ferruzzi F, Fratellanza G, Scarpato N, Borgia G. Gentile I, et al. Among authors: buonomo ar. In Vivo. 2013 Nov-Dec;27(6):773-7. In Vivo. 2013. PMID: 24292581

10

Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A.

Gentile I, Borgia F, Coppola N, Buonomo AR, Castaldo G, Borgia G. Gentile I, et al. Among authors: buonomo ar. Curr Med Chem. 2014;21(12):1391-404. doi: 10.2174/0929867321666131228222215. Curr Med Chem. 2014. PMID: 24372205 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters